Adamas Pharmaceuticals (ADMS) PT Raised to $9 at Cowen on Expaded Gocovri Label
Tweet Send to a Friend
Cowen analyst Ken Cacciatore raised the price target on Adamas Pharmaceuticals (NASDAQ: ADMS) to $9.00 (from $6.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
